Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

LANDSTAR SYSTEM INC (LSTR)

8-K Debt Issuance confidence 90% filed 2026-07-06 Item 1.01

Landstar entered into a Third Amended and Restated Credit Agreement on June 30, 2026, establishing a $300 million revolving credit facility with an additional $500 million accordion feature and a five-year termination date (June 30, 2031). This represents a material amendment to the company's direct financial obligations and replaces the prior credit agreement.

View raw filing on EDGAR →

American Bitcoin Corp. (ABTC)

8-K Governance Other confidence 85% filed 2026-07-06 Item 3.03

American Bitcoin Corp. effected a 1-for-15 reverse stock split of its Class A and Class B common stock on July 2, 2026, reducing outstanding shares from approximately 1.09 billion to 73 million. The reverse split was approved by stockholders on June 22, 2026, and was undertaken to maintain compliance with Nasdaq's minimum bid price listing requirement.

View raw filing on EDGAR →

Nuvation Bio Inc. (NUVB)

8-K Debt Issuance confidence 98% filed 2026-07-06 Item 2.03

Nuvation Bio completed a registered public offering of $287.5 million aggregate principal amount of 0.75% Convertible Senior Notes due 2032, including the full exercise of a $37.5 million greenshoe over-allotment option on July 6, 2026, generating net proceeds of approximately $277.6 million after underwriting costs.

View raw filing on EDGAR →

Vroom, Inc. (VRMWW)

8-K Debt Issuance confidence 70% filed 2026-07-06 Item 1.01

Vroom entered into Amendment No. 29 to its warehouse credit facility, which materially restructures the terms by modifying financial covenants (leverage ratio, tangible net worth, advance rate), extending the commitment termination date from July 2, 2026 to June 2, 2027, and adding a new performance guaranty from VFH.

View raw filing on EDGAR →

VERTEX PHARMACEUTICALS INC / MA (VRTX)

8-K M&A activity confidence 99% filed 2026-07-06 Item 1.01

Vertex Pharmaceuticals entered into a definitive merger agreement on July 6, 2026, to acquire Crinetics Pharmaceuticals for $85 per share in cash, representing a $10 billion total transaction ($8.8 billion net of cash). The acquisition is expected to be transformative, adding endocrinology assets including PALSONIFY and atumelnant to Vertex's pipeline, with $5 billion+ peak sales opportunity and accretion to non-GAAP operating income by 2029.

View raw filing on EDGAR →

IMMUNIC, INC. (IMUX)

8-K Exec appointment confidence 85% filed 2026-07-06 Item 5.02

The filing discloses two executive changes: Tamar Howson's resignation from the Board and Compensation Committee on June 29, 2026, and Erik Lundgren's appointment as a Class II director on July 5, 2026. While both events are disclosed, the principal action emphasized is Lundgren's appointment to the Board following the Nominating and Corporate Governance Committee's recommendation. The appointment of the CEO to the Board is the forward-looking material event, making exec_appointment the most salient classification.

View raw filing on EDGAR →

TIMKEN CO (TKR)

8-K Debt Issuance confidence 92% filed 2026-07-06 Item 1.01

On July 2, 2026, the Company entered into a Sixth Amended and Restated Credit Agreement establishing a $1.2 billion unsecured revolving credit facility maturing in 2031, representing a material refinancing and extension of its existing revolving credit agreement.

View raw filing on EDGAR →

REE Automotive Ltd. (REE)

6-K Delisting risk confidence 98% filed 2026-07-06 EX-99.1

REE Automotive received a delisting notice from Nasdaq on June 30, 2026, determining that the Company's Class A ordinary shares will be delisted from the Nasdaq Capital Market effective July 7, 2026, due to failure to regain compliance with the Minimum Bid Price Requirement (closing bid price below $1.00 per share for 30 consecutive business days). The Company exhausted its 180-day cure periods and does not intend to request a hearing. This is a terminal delisting determination, not merely a warning or deficiency notice.

View raw filing on EDGAR →

New ERA Energy & Digital, Inc. (NUAIW)

8-K Exec appointment confidence 92% filed 2026-07-06 Item 5.02

The filing discloses multiple executive appointments effective July 1, 2026: Charles Nelson as Chairman and CEO (promoted from President and COO), Ted Warner as President and director (promoted from CFO), and José Rodriguez as Chief Operating Officer (promoted from VP). While the section also includes an executive departure (E. Will Gray II's resignation as director and demotion from CEO to President, Permian), the principal disclosed actions center on the appointments and promotions of three executives to senior leadership roles, with corresponding employment agreement amendments and compensatory arrangements. These leadership changes are material to investors assessing the registrant's governance and strategic direction.

View raw filing on EDGAR →

Alarum Technologies Ltd. (ALAR)

6-K Legal Other confidence 85% filed 2026-07-06 EX-99.1

This press release discloses a law enforcement action by the FBI involving seizure of domains associated with NetNut (Alarum's subsidiary), resulting in service disruptions that the Company acknowledges are "likely to have a material adverse effect on the Company's operations, financial results and its ability to provide certain services to customers." While the disclosure involves potential regulatory/law enforcement investigation rather than a formal litigation filing or settlement, it is a material legal/regulatory event that does not fit the specific categories of material_litigation (no lawsuit filed), cybersecurity_incident (no breach disclosed), or covenant_breach (no debt default). The domain seizures and ongoing investigation constitute a significant legal/regulatory matter warranting disclosure.

View raw filing on EDGAR →

Zoned Properties, Inc. (ZDPY)

8-K Financial Other confidence 72% filed 2026-07-06 Item 8.01

The disclosure reports completion of a partial real estate disposition—closing on two of three properties (Green Valley and Kingman) for $1.0 million in aggregate proceeds on June 30, 2026, with the third property (Chino Valley) closing deferred to August 31, 2026. While this is a sale of assets, it does not rise to the level of a material acquisition, disposition, or change of control (which would trigger ma_activity); rather, it is a discrete asset sale that affects the company's financial position and liquidity. The transaction is material to investors as it represents a significant capital event and reduction in the company's real estate holdings.

View raw filing on EDGAR →

Bitdeer Technologies Group (BTDR)

6-K Exec departure confidence 95% filed 2026-07-06

Ms. Chao Suo has tendered her resignation as a member of the Company's board of directors and compensation committee member, effective July 31, 2026. This is a clear executive departure disclosure. The resignation of a board member and committee member is material to investors assessing the registrant's governance and leadership structure, even though the resignation is attributed to personal reasons rather than dispute.

View raw filing on EDGAR →

Radiopharm Theranostics Ltd (RDPTF)

6-K Financial Other confidence 85% filed 2026-07-06 EX-99.1

Radiopharm announces receipt of a A$5.9M R&D tax refund from the Australian Government for the 2025 financial year. This is a material financial event — a significant cash inflow that the company explicitly states "will provide important funding for continued development" of its product pipeline. While not a traditional debt issuance, equity offering, or dividend, it is a material financial event that affects the registrant's liquidity and capital position, and does not fit the specific named financial categories (debt_issuance, dividend_distribution, etc.).

View raw filing on EDGAR →

Can-Fite BioPharma Ltd. (CANF)

6-K Operational Other confidence 85% filed 2026-07-06 EX-99.1

This press release announces completion of patient enrollment (247 patients) in a pivotal Phase 3 clinical trial for Piclidenoson in psoriasis, with interim analysis expected Q4 2026/Q1 2027 under FDA and EMA-agreed protocol. This is a material clinical development milestone for a clinical-stage biotech company, but it is not a discrete event type in the taxonomy (not earnings, M&A, litigation, or a specific financial/governance action). It represents a significant operational/strategic advancement in the company's drug development pipeline that would affect a reasonable investor's assessment of the registrant's progress toward regulatory approval and commercialization.

View raw filing on EDGAR →

Keel Infrastructure Corp. (KEEL)

8-K Exec appointment confidence 95% filed 2026-07-06 Item 5.02

Keel Infrastructure Corp. appointed Ganesh Aiyer as President, effective July 6, 2026, reporting directly to CEO Ben Gagnon. Aiyer brings 25 years of experience from senior roles at Digital Realty Trust, Schneider Electric, and Dell Technologies, and will be responsible for commercial strategy and pipeline expansion. The appointment includes compensatory arrangements comprising a $500,000 base salary, bonus plan eligibility, 100,000 stock options, $1.5M in RSUs, and severance provisions.

View raw filing on EDGAR →

Wellchange Holdings Co Ltd (WCT)

6-K Shareholder vote confidence 95% filed 2026-07-06

The 6-K discloses the final voting results from three shareholder meetings held on July 6, 2026: a Class A Meeting, a Class B Meeting, and an Annual General Meeting. The results include approval of significant structural changes including an increase in Class B voting rights from 35 to 100 votes per share, adoption of amended articles of association, a 1-for-400 Class A share consolidation, a par value reduction, and an authorized share capital increase. These governance and capital structure changes are material to investors and directly correspond to Item 5.07 disclosure requirements.

View raw filing on EDGAR →

Grande Group Ltd/HK (GRAN)

6-K Exec appointment confidence 95% filed 2026-07-06

On July 1, 2026, the Board appointed Ms. Sha, XIA as a Director of Grande Group Limited to fill the vacancy created by Mr. Ying Wo Sammy, HO's resignation on April 15, 2026. The filing discloses the appointment of a director, her employment agreement with an annual salary of HK$180,000, and her professional background. This is a clear executive appointment event material to investors assessing the company's leadership composition.

View raw filing on EDGAR →

Ondas Inc. (ONDS)

8-K M&A activity confidence 98% filed 2026-07-06 Item 1.01

Ondas Inc. completed the acquisition of DZYNE Technologies, LLC (High Point UAS, LLC) on July 2, 2026, for $875 million in total consideration ($200 million cash and 85 million shares of common stock valued at $675 million). The acquisition materially expands Ondas' autonomous defense platform across persistent intelligence, aerial security, counter-UAS, and autonomous effects, with projected 2027 revenue exceeding $300 million and 80%+ revenue CAGR through 2028.

View raw filing on EDGAR →

Immuron Ltd (IMRN)

6-K Operational Other confidence 75% filed 2026-07-06 EX-99.1

Immuron announced engagement of Pullan Consulting to advance partnering strategy for IMM-529, a clinical-stage CDI therapeutic with FDA IND approval. The disclosure details the company's strategic initiative to secure a development and commercialization partner, including market opportunity assessment (projected $400M base case annual revenue) and historical CDI deal benchmarks. This is a material operational/strategic milestone advancing a key asset toward commercialization, but does not fit discrete event categories like M&A (no deal executed), exec changes, or financial events—it is a business development initiative that would affect investor assessment of the company's strategy and value creation path.

View raw filing on EDGAR →

OneConstruction Group Ltd (ONEG)

6-K Exec appointment confidence 95% filed 2026-07-06

The 6-K discloses the Board's resolution on July 3, 2026 to appoint Dr. Michael HE as a director to fill a vacancy created by Mr. Cheung Kam Cheung's prior resignation. The appointment is accompanied by a director's agreement specifying annual cash compensation of HK$120,000. This is a clear executive appointment event under the taxonomy, material to investors as it affects board composition and governance.

View raw filing on EDGAR →

Zhibao Technology Inc. (ZBAO)

6-K Exec appointment confidence 92% filed 2026-07-06

The 6-K discloses the appointment of Guangtong Ren as director and Chief Financial Officer, and the appointment of three independent directors (Jun Ma, YiYun Dai, and Han Tang) with committee assignments, all effective July 1, 2026. While the report also mentions concurrent resignations of four directors/officers, the principal disclosed action is the appointment of new leadership, making exec_appointment the primary classification. This is material as it involves changes to the company's senior financial and governance leadership.

View raw filing on EDGAR →

Maison Solutions Inc. (MSS)

8-K M&A activity confidence 95% filed 2026-07-06 Item 1.01

Maison Solutions' subsidiaries entered into an Asset Purchase Agreement on July 1, 2026, to divest two store locations (San Gabriel and Monrovia) and related assets for $4.5 million as part of a strategic realignment to eliminate loss-generating operations.

View raw filing on EDGAR →

Steakholder Foods Ltd. (MTTCF)

6-K Operational Other confidence 85% filed 2026-07-06 EX-99.1

This press release announces a material operational milestone: expanded retail distribution of Steakholder Foods' Perfecta™ Premium Plant-Based Meat through KeHE Distributors, one of the largest natural and specialty food distributors in the U.S., with an initial rollout in the Northeastern United States and a structured roadmap for rapid expansion through Q3 and Q4 2026. This represents a significant commercial advancement for the company's core product line and market entry strategy, but does not fit the specific event categories (M&A, earnings, executive changes, debt, etc.); it is a material operational/strategic business milestone warranting disclosure to investors.

View raw filing on EDGAR →

Big Digital Energy, Inc. (BGDE)

8-K M&A activity confidence 92% filed 2026-07-06 Item 3.02

Big Digital Energy entered into a 50/50 joint venture with 10NetZero and signed a letter of intent to acquire a 50% interest in a power-ready industrial site in Hood County, Texas for AI datacenter development, with planned capital deployment of approximately $3.56 billion across three development tracks. This material acquisition of real property and infrastructure assets represents a substantial strategic transaction that will significantly expand the company's operational capacity and asset base.

View raw filing on EDGAR →

NewGenIvf Group Ltd (NIVFW)

6-K Operational Other confidence 75% filed 2026-07-06 EX-99.1

This press release announces NewGen's planned expansion into the UAE/GCC market with a new cell sorting and cytometry leasing business, supported by a Big Four valuation of US$19 million equity value. The disclosure also announces the appointment of Nadeem Malik as Senior Strategic Advisor to lead this expansion. While the appointment of a senior strategic advisor could be classified as exec_appointment, the primary focus and materiality of the disclosure centers on the strategic business expansion initiative, the independent valuation supporting it, and the operational/commercial opportunity in a new high-growth market. This is a material operational and strategic development that would affect a reasonable investor's assessment of the company's growth prospects and diversification strategy.

View raw filing on EDGAR →

Defi Technologies, Inc. (DEFT)

6-K Shareholder vote confidence 95% filed 2026-07-06 EX-99.6

At its Annual General and Special Meeting held on June 29, 2026, Defi Technologies shareholders approved six material governance matters: setting the board at six directors (93.1% in favour), electing all six director nominees (76–95% support), reappointing auditors (92% in favour), approving a 1:12 share consolidation (73% in favour), confirming removal of Canadian residency requirements for directors (90% in favour), and adopting an Advance Notice By-Law (64% in favour). These results establish the board composition and authorize a significant capital structure change.

View raw filing on EDGAR →

Solstice Advanced Materials Inc. (SOLS)

8-K M&A activity confidence 99% filed 2026-07-06

The filing discloses a definitive merger agreement entered into on July 6, 2026, whereby Solstice Advanced Materials will acquire Element Solutions in a cash-and-stock transaction valued at approximately $14.5 billion. The joint press release and investor presentation detail the strategic rationale, transaction structure ($10.00 cash plus 0.500 Solstice shares per Element share), financing arrangements, and expected closing in H1 2027. This is a material acquisition creating an industry-leading advanced materials platform with significant strategic and financial implications.

View raw filing on EDGAR →

Park Ha Biological Technology Co., Ltd. (BYAH)

6-K Shareholder vote confidence 80% filed 2026-07-06 EX-99.1

Park Ha Biological Technology held shareholder meetings on July 13, 2026, to vote on material governance and capital structure proposals including a massive increase in authorized share capital from 3 billion to 300 billion shares, authorization for the Board to effect share consolidations (2-for-1 to 5,000-for-1 ratio) and subdivisions (2-for-1 to 100-for-1 ratio), and an increase in Class B voting rights from 20 to 100 votes per share. These proposals would materially affect shareholder interests through potential dilution and significant changes to voting power and control dynamics.

View raw filing on EDGAR →

Bespoke Extracts, Inc. (BSPK)

8-K Debt Issuance confidence 75% filed 2026-07-06 Item 2.03

Bespoke Extracts amended its existing Senior Secured Promissory Notes, extending the maturity date from June 30, 2026 to August 14, 2026, increasing the interest rate from 15% to 17% per annum, and issuing 287,719 shares of common stock (valued at approximately $41,000) as consideration for the amendment.

View raw filing on EDGAR →

Park Ha Biological Technology Co., Ltd. (BYAH)

6-K Operational Other confidence 75% filed 2026-07-06 EX-99.1

This press release announces Park Ha Biological's successful approval and launch of an official Amazon North America store, described as "a critical milestone in the execution of the Company's global expansion strategy" and marking the company's transition from a "premium domestic brand" to an "emerging international brand." While this is a significant operational and strategic development—opening a major new distribution channel and market—it does not fit the specific event-type categories (M&A, earnings, executive changes, debt, etc.). The disclosure is material because it represents a material strategic expansion into a major new geographic market and sales channel, which would affect a reasonable investor's assessment of the company's growth prospects and competitive positioning.

View raw filing on EDGAR →

ParaZero Technologies Ltd. (PRZO)

6-K Operational Other confidence 75% filed 2026-07-06 EX-99.1

ParaZero announced receipt of a significant purchase order valued at over $1 million from a U.S.-based customer, with expected deliveries commencing in Q4 2026 over 12–18 months. This represents a material operational and commercial milestone for the aerospace defense company, demonstrating customer confidence and supporting its growth strategy. While not a discrete M&A transaction, debt issuance, or other specifically-named event type, this material customer contract and revenue-generating order is a significant operational development that would affect a reasonable investor's assessment of the company's commercial traction and near-term revenue prospects.

View raw filing on EDGAR →

Eureka Acquisition Corp (EURKU)

8-K Shareholder vote confidence 92% filed 2026-07-06 Item 5.07

Eureka Acquisition Corp held an Extraordinary General Meeting on June 5, 2026, at which shareholders approved two material proposals: (1) a Charter Amendment extending the business combination deadline from July 3, 2026 to July 3, 2027 with optional monthly extensions, and (2) appointment of Marcum Asia CPAs LLP as independent auditor. Both proposals passed with substantial majorities. As a result of the charter amendment vote, 2,655,132 Class A Ordinary Shares were redeemed, leaving 733,101 Class A and 1,437,500 Class B shares outstanding.

View raw filing on EDGAR →

Eureka Acquisition Corp (EURKU)

8-K Governance Other confidence 72% filed 2026-07-06 Item 1.01

Eureka Acquisition Corp entered into an amendment to its trust agreement on June 30, 2026, in connection with shareholder approval of the Charter Amendment Proposal. The Trust Amendment modifies the terms governing the trust account, including monthly extension fees and cure periods for non-payment, with material consequences (immediate cessation of operations and liquidation) for non-compliance.

View raw filing on EDGAR →

Wellchange Holdings Co Ltd (WCT)

6-K Dilutive issuance confidence 92% filed 2026-07-06

The Company issued 1,465,043 newly created Class B ordinary shares to CEO Shek Kin Pong at US$0.9363 per share (US$1.37M aggregate) in a private subscription agreement closed July 2, 2026. This is a dilutive equity issuance to an insider that increases his voting power to 98.42% of total voting power. The transaction was structured under Regulation S as an offshore private placement, making it an unregistered equity sale characteristic of dilutive issuances under Item 3.02.

View raw filing on EDGAR →

Churchill Capital Corp XI (CCXIW)

8-K Debt Issuance confidence 85% filed 2026-07-06 Item 1.01

Churchill Capital Corp XI issued an unsecured promissory note of up to $1,500,000 to its sponsor for working capital needs. Although the note is convertible into equity units at the sponsor's option, the primary transaction is the creation of a direct financial obligation constituting a debt issuance.

View raw filing on EDGAR →

Perpetuals.com Ltd (PDC)

6-K Shareholder vote confidence 95% filed 2026-07-06

The 6-K discloses results of an Extraordinary General Meeting held on April 30, 2026, where shareholders voted on and approved a resolution for reduction of stated capital. The filing reports vote tallies (8,319,502 for, 81,540 against, 1,130 abstain) representing 36.81% of exercisable votes. This is a direct disclosure of shareholder vote results on a material corporate action (capital reduction), matching the shareholder_vote_results taxonomy.

View raw filing on EDGAR →

Haoxi Health Technology Ltd (HAO)

6-K Shareholder vote confidence 95% filed 2026-07-06

The 6-K discloses results of an extraordinary general meeting held on July 6, 2026, where shareholders voted on three proposals: (1) a special resolution to reduce and reorganize the Company's authorized share capital from US$35.2 trillion to US$11 million with a dramatic reduction in par value per share from US$0.32 to US$0.0000001, (2) adoption of amended memorandum and articles of association to reflect the capital reduction, and (3) an adjournment proposal. All three proposals were approved with voting tallies provided. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the capital restructuring is material to investors as it fundamentally alters the share structure and capitalization.

View raw filing on EDGAR →

Profusa, Inc. (NVACW)

8-K Governance Other confidence 85% filed 2026-07-06 Item 5.03

Profusa effected a 1-for-25 reverse stock split of its common stock, approved by stockholders and implemented via amendment to the certificate of incorporation filed with Delaware on July 2, 2026, effective July 7, 2026. The reverse split consolidates outstanding shares from approximately 13.2 million to 530 thousand shares, materially affecting share count, ownership percentages, per-share metrics, and trading mechanics for all shareholders.

View raw filing on EDGAR →

BANK OF CHILE (BCH)

6-K Debt Issuance confidence 95% filed 2026-07-06

Bank of Chile placed senior, dematerialized bearer bonds (Serie FG Bonds) in the local Chilean market on July 6, 2026, for a total amount of CLF 880,000 with maturity November 1, 2030, at an average placement rate of 2.81%. This is a creation of a new direct financial obligation and is disclosed as "Material Information" to the Chilean Financial Market Commission, meeting the definition of debt_issuance.

View raw filing on EDGAR →

Longeveron Inc. (LGVN)

8-K Exec appointment confidence 92% filed 2026-07-06 Item 5.02

Marie Washburn appointed as Senior Vice President and Chief Financial Officer effective July 13, 2026, with compensation terms including $340,000 base salary, 45% performance bonus target, and 130,000 RSUs. Dr. Arjun Desai also appointed to the Board as a Class III director on July 2, 2026.

View raw filing on EDGAR →

Longeveron Inc. (LGVN)

8-K Shareholder vote confidence 95% filed 2026-07-06 Item 5.07

Longeveron's Annual Meeting held July 1, 2026 approved six proposals: election of three Class II directors (Stephen Willard, Leah Rush Cann, Deborah Ascheim), charter amendments to increase authorized Class A shares and authorize a reverse stock split (1:2 to 1:20 ratio), amendment to the 2021 Incentive Award Plan to increase authorized shares by 5,000,000, ratification of CBIZ CPAs P.C. as independent auditor, and approval of an adjournment proposal.

View raw filing on EDGAR →

China SXT Pharmaceuticals, Inc. (SXTC)

6-K Dilutive issuance confidence 92% filed 2026-07-06

The 6-K discloses entry into a Securities Purchase Agreement on July 3, 2026, under which China SXT Pharmaceuticals agreed to issue Class A ordinary shares to an institutional investor for up to $30 million in aggregate, with an initial closing of $3.15 million expected July 6, 2026. The securities were issued in reliance on Regulation D (private placement exemption), not registered under the Securities Act. This is a dilutive equity issuance characteristic of a PIPE or private placement, material to investors assessing ownership dilution and capital structure.

View raw filing on EDGAR →

Maison Solutions Inc. (MSS)

8-K M&A activity confidence 95% filed 2026-07-06 Item 1.01

Maison Solutions Inc. entered into and closed an Equity Purchase Agreement on July 2, 2026, to sell its 91.67% equity interest in Super HK of El Monte, Inc. to DNL Management Inc. This material disposition of a subsidiary represents a substantial portion of the Company's assets and was completed simultaneously with execution.

View raw filing on EDGAR →

Zoomcar Holdings, Inc. (ZCARW)

8-K Dilutive issuance confidence 92% filed 2026-07-06

The filing discloses the third closing of a private placement of Series A Convertible Preferred Stock and Warrants under Section 4(a)(2) and Regulation D Rule 506(c). The Company issued 195 Units (195 Preferred Shares convertible at $0.05 per share and 195 Warrants exercisable at $0.0625 per share) for $195,000 gross proceeds. The Preferred Shares and Warrants are convertible/exercisable into common stock, creating significant dilution to existing shareholders. Item 3.02 explicitly addresses "Unregistered Sales of Equity Securities," confirming this is a dilutive equity issuance requiring registration rights and liquidated damages provisions.

View raw filing on EDGAR →

Baiya International Group Inc. (BIYA)

6-K M&A activity confidence 95% filed 2026-07-06

The 6-K discloses entry into a Stock Purchase Agreement on July 2, 2026, whereby Baiya International Group Inc. sold all of its equity interests in Starfish Technology-FZE to Shengshi International Group Inc. for US$1,000,000 in cash. This constitutes a material disposition of a subsidiary or operating entity, falling squarely within the ma_activity category (Item 1.02 / 2.01 equivalent). The transaction is material to a reasonable investor as it represents a complete divestiture of an asset previously acquired under a prior agreement dated September 19, 2025.

View raw filing on EDGAR →

TOYO Co., Ltd (TOYWF)

6-K Exec appointment confidence 95% filed 2026-07-06 EX-99.1

The press release announces the appointment of Yasunari Harada as Chief Financial Officer and a director of TOYO Co., Ltd, effective July 1, 2026. While the disclosure also mentions the concurrent resignation of the prior CFO, Taewoo "Raymond" Chung, the principal disclosed action is Harada's appointment to a senior executive and board position. The appointment of a CFO with 30+ years of senior leadership experience at major investment banks is material to a reasonable investor's assessment of the company's financial strategy and governance.

View raw filing on EDGAR →

Rocky Mountain Chocolate Factory, Inc. (RMCF)

8-K Exec appointment confidence 92% filed 2026-07-06 Item 5.02

The filing discloses the appointment of Allen C. Harper as Interim Chief Executive Officer and Principal Executive Officer of Rocky Mountain Chocolate Factory, Inc., effective June 29, 2026. While the disclosure also mentions Harper's resignation from his prior CEO role at American Heritage Railways and includes compensatory arrangements ($200,000 in cash and restricted stock units), the principal disclosed action is the appointment to the CEO position. This is a material executive appointment affecting the registrant's leadership.

View raw filing on EDGAR →

Silvaco Group, Inc. (SVCO)

8-K Dilutive issuance confidence 85% filed 2026-07-06 Item 8.01

Silvaco is issuing 69,062 shares of common stock to a former Tech-X equityholder as consideration for the Tech-X acquisition—specifically for contingent earnout consideration and post-closing purchase adjustments. This is a dilutive equity issuance without cash proceeds to the company, fitting the definition of dilutive_issuance. While the shares are issued in connection with an M&A transaction (Tech-X Acquisition), the 8-K Item 8.01 disclosure centers on the equity issuance itself rather than the acquisition completion, and the company receives no cash proceeds, making this a capital-dilutive event material to shareholders.

View raw filing on EDGAR →

Solstice Advanced Materials Inc. (SOLS)

8-K M&A activity confidence 98% filed 2026-07-06

The filing discloses entry into an Agreement and Plan of Merger on July 6, 2026, whereby Solstice Advanced Materials Inc. will acquire Element Solutions Inc. through a two-step merger structure. The Merger Agreement has been unanimously approved by both boards and contemplates issuance of Solstice common stock as merger consideration (0.500 shares per Element Solutions share plus $10 cash). This is a material acquisition transaction requiring Item 1.01 disclosure and triggering Rule 425 written communications obligations.

View raw filing on EDGAR →

Quantum Cyber N.V. (QUCY)

8-K Exec appointment confidence 75% filed 2026-07-06 Item 5.02

The Item 5.02 disclosure centers on two distinct executive actions: (1) Peter O'Rourke's appointment as President of Quantum Drones (a wholly owned subsidiary) under a new employment agreement with specified compensation (base salary of $20,833.33/month, stock options for 112,859 shares at $1.45/share), and (2) Louis Buffalino's appointment as a director and committee member effective July 1, 2026. While the section also includes compensatory details, the principal disclosed actions are the appointments themselves. The appointment of a President to a material subsidiary and a director to the Board are material governance events affecting the registrant's leadership structure.

View raw filing on EDGAR →